104 related articles for article (PubMed ID: 11150146)
1. [Metaphylaxis of nephrolithiasis].
Uzdenov MA
Urologiia; 1999; (5):15-7. PubMed ID: 11150146
[TBL] [Abstract][Full Text] [Related]
2. [Total urinary protein in different types of nephrolithiasis].
Bilobrov VM; Mironov OL; Minas'iants EZ; Bilobrova IG; Shul'gin NM
Urol Nefrol (Mosk); 1991; (4):33-7. PubMed ID: 1949415
[TBL] [Abstract][Full Text] [Related]
3. Prognosis of urolithiasis and nephrocalcinosis in hypomagnesemia.
Revúsová V; Zvara V; Karlíková L; Suchánek B
Czech Med; 1985; 8(4):207-13. PubMed ID: 3937709
[TBL] [Abstract][Full Text] [Related]
4. Eicosapentaenoic acid has a preventive effect on the recurrence of nephrolithiasis.
Yasui T; Suzuki S; Itoh Y; Tozawa K; Tokudome S; Kohri K
Urol Int; 2008; 81(2):135-8. PubMed ID: 18758209
[TBL] [Abstract][Full Text] [Related]
5. Renal stones in the tropics.
Robertson WG
Semin Nephrol; 2003 Jan; 23(1):77-87. PubMed ID: 12563603
[TBL] [Abstract][Full Text] [Related]
6. [Inhibitors of crystallization and calcium nephrolithiasis].
Baumann JM
Ther Umsch; 1980 May; 37(5):363-72. PubMed ID: 6248999
[No Abstract] [Full Text] [Related]
7. [Urolithiasis. Review of present knowledge of epidemiology, pathogenesis, metaphylaxis and treatment].
Hradec E
Cas Lek Cesk; 1989 Feb; 128(9):257-61. PubMed ID: 2663171
[TBL] [Abstract][Full Text] [Related]
8. Enteric hyperoxaluria, nephrolithiasis, and oxalate nephropathy: potentially serious and unappreciated complications of Roux-en-Y gastric bypass.
Nelson WK; Houghton SG; Milliner DS; Lieske JC; Sarr MG
Surg Obes Relat Dis; 2005; 1(5):481-5. PubMed ID: 16925274
[TBL] [Abstract][Full Text] [Related]
9. [The use of 1-alpha-cholecalciferol in subjects treated for a prolonged time with diphosphonates for recurrent calcium nephrolithiasis].
Jacobellis U; Salerno G; Ruotolo G
Arch Esp Urol; 1984 Dec; 37 Suppl 1():577-81. PubMed ID: 6100036
[No Abstract] [Full Text] [Related]
10. The etiology of urolithiasis in HIV infected patients.
Nadler RB; Rubenstein JN; Eggener SE; Loor MM; Smith ND
J Urol; 2003 Feb; 169(2):475-7. PubMed ID: 12544290
[TBL] [Abstract][Full Text] [Related]
11. [Diet and nutrition in nephrolitiasis].
Miggiano GA; Migneco MG
Clin Ter; 2007; 158(1):49-54. PubMed ID: 17405659
[TBL] [Abstract][Full Text] [Related]
12. Body size and 24-hour urine composition.
Taylor EN; Curhan GC
Am J Kidney Dis; 2006 Dec; 48(6):905-15. PubMed ID: 17162145
[TBL] [Abstract][Full Text] [Related]
13. Lithogenic risk factors for renal stones in patients with Crohn's disease.
Buño Soto A; Torres Jiménez R; Olveira A; Fernández-Blanco Herraiz I; Montero García A; Mateos Antón F
Arch Esp Urol; 2001 Apr; 54(3):282-92. PubMed ID: 11432047
[TBL] [Abstract][Full Text] [Related]
14. [Role of physico-chemical and biochemical composition of urine in the genesis of combined nephrolithiasis and cholelithiasis].
Neĭmark AI; Fidirkin AV; Savenko VI
Urologiia; 2002; (2):37-40. PubMed ID: 12077822
[TBL] [Abstract][Full Text] [Related]
15. Tea and coffee as the main sources of oxalate in diets of patients with kidney oxalate stones.
Gasińska A; Gajewska D
Rocz Panstw Zakl Hig; 2007; 58(1):61-7. PubMed ID: 17711092
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of fasting hypercalciuria associated with increased citraturia in the ambulatory evaluation of nephrolithiasis.
Damasio B; Massarino F; Durand F; Banchero R; Bottino P; De Franchis V; Carmignani G; Cannella G
J Nephrol; 2005; 18(3):262-6. PubMed ID: 16013013
[TBL] [Abstract][Full Text] [Related]
17. Metabolic risk factors and the impact of medical therapy on the management of nephrolithiasis in obese patients.
Ekeruo WO; Tan YH; Young MD; Dahm P; Maloney ME; Mathias BJ; Albala DM; Preminger GM
J Urol; 2004 Jul; 172(1):159-63. PubMed ID: 15201761
[TBL] [Abstract][Full Text] [Related]
18. [Etiopathogenesis and clinical aspects of nephrolithiasis--at present].
Ferrari L; Meschi M; Musini S; Frattini A; Savazzi GM
Recenti Prog Med; 2003 Mar; 94(3):136-41. PubMed ID: 12677782
[TBL] [Abstract][Full Text] [Related]
19. Recurrence of renal lithiasis.
Grases F; Costa-Bauzá A; Ramis M; Montesinos V; Conte A
Scand J Urol Nephrol; 2003; 37(6):482-6. PubMed ID: 14675921
[TBL] [Abstract][Full Text] [Related]
20. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
Stoller ML; Chi T; Eisner BH; Shami G; Gentle DL
J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
